MITO99 OFFICIAL GRUP
IDR 10,000.00
mito99 Mito-99-0103, Initially developed by Mito BioPharm LLC, Now, its global hhest R&D status is Preclinical, Therapeutic Areas: Endocrinology and Metabolic Disease, Active Indication:. MITO99
mito99 login, MITO99 link alternatif resmi Nihon University Indonesia 2025 dengan akses cepat, aman, dan terpercaya untuk informasi akademik dan pendaftaran on.
Quantity: